Hansa Biopharma to participate in three upcoming investor conferences
Lund, Sweden August 21, 2019. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that the Company’s management team will participate in the following upcoming investor conferences:
- The Goldman Sachs Ninth Annual Biotech Symposium in London on Friday, September 6, 2019.
- The Morgan Stanley 17th Annual Global Healthcare Conference in New York City, NY Tuesday, September 10, 2019, with a presentation at 1:30 PM EST/ 19:30 CET on the same day.
- The Bank of America Merrill Lynch Global Healthcare Conference 2019 in London from Thursday, September 19, 2019 to Friday, September 20, 2019, with a presentation at 14:45 CET on Friday September 20.
A live webcast of the Morgan Stanley presentation will be available on the Events & Webcast page of the Company's website, www.hansabiopharma.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.
For further information, please contact:
Klaus Sindahl, Head of Investor Relations
Mobile: +46 (0) 709-298 269
Rolf Gulliksen, Head of Corporate Communications
Mobile: +46 (0) 733-328 634